Dr Farshad Guirakhoo | CSO
GeoVax, Inc.

Dr Farshad Guirakhoo, CSO, GeoVax, Inc.

Before joining GeoVax in 2015, Dr. Guirakhoo served in senior management and scientific roles within the biotechnology industry with Vaxess Technologies, Hookipa Biotech, Sanofi Pasteur, Acambis, Inc. and OraVax, Inc. In his scientific career, Dr. Guirakhoo has filed over 90 patent applications and is author/co-author of more than 80 peer reviewed publications, including book chapters. He was instrumental in the development and commercialization of the Imojev Japanese encephalitis virus vaccine and the Dengvaxia vaccine for Dengue virus


DC Co-conference Day 2 April 4 @ 09:40

MVA-VLP as a Plug and Play platform for development of safe and effective single dose vaccines for emerging infectious diseases, preclinical data for Zika, Ebola and Lassa as examples

back to speakers